Country: Malta
Language: English
Source: Medicines Authority
FINASTERIDE
Merck Sharp & Dohme Limited Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom
G04CB01
FINASTERIDE 5 mg
COATED TABLET
FINASTERIDE 5 mg
POM
UROLOGICALS
Withdrawn
2006-04-10
PACKAGE LEAFLET: INFORMATION FOR THE USER PROSCAR® 5 MG FILM-COATED TABLETS (FINASTERIDE) This medicine is for use in men only READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU . Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What Proscar is and what it is used for 2. What you need to know before you take Proscar 3. How to take Proscar 4. Possible side effects 5. How to store Proscar 6. Contents of the pack and other information 1. WHAT PROSCAR IS AND WHAT IT IS USED FOR Proscar contains a medicine called finasteride. This belongs to a group of medicines called ‘5-alpha reductase inhibitors’. Proscar shrinks the prostate gland in men when it is swollen. The prostate gland is found underneath the bladder (but only in men). It produces the fluid found in semen. A swollen prostate gland can lead to a condition called ‘benign prostatic hyperplasia’ or BPH. WHAT IS BPH? If you have BPH it means that your prostate gland is swollen. It can press on the tube that urine passes through, on its way out of your body. This can lead to problems such as: feeling like you need to pass urine more often, especially at night feeling th Read the complete document
1 1 NAME OF THE MEDICINAL PRODUCT PROSCAR® 5mg film-coated Tablets (finasteride) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg of finasteride. 3 PHARMACEUTICAL FORM Blue-coloured, apple-shaped, film-coated tablets marked ‘Proscar’ on one side and ‘MSD 72’ on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ‘Proscar’ is indicated for the treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate to: cause regression of the enlarged prostate, improve urinary flow and improve the symptoms associated with BPH reduce the incidence of acute urinary retention and the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The recommended adult dose is one 5 mg tablet daily, with or without food. ‘Proscar’ can be administered alone or in combination with the alpha-blocker doxazosin (see section 5.1 ‘Pharmacodynamic properties’). Although early improvement in symptoms may be seen, treatment for at least six months may be necessary to assess whether a beneficial response has been achieved. Thereafter, treatment should be continued long term. No dosage adjustment is required in the elderly or in patients with varying degrees of renal insufficiency (creatinine clearances as low as 9 ml/min). There are no data available in patients with hepatic insufficiency. ‘Proscar’ is contra-indicated in children. 4.3 CONTRAINDICATIONS ‘Proscar’ is not indicated for use in women or children. ‘Proscar’ is contraindicated in the following: Hypersensitivity to any co Read the complete document